Advancing Tomorrow’s Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics Development

By sjmartinez • January 24, 2025

Van Naarden JS, Herrmann K, Czernin J. Advancing Tomorrow's Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics Development. J Nucl Med. 2025 Jan 23:jnumed.124.269354. doi: 10.2967/jnumed.124.269354. Epub ahead of print. PMID: 39848767.

Tags: Cardiology/Epi, Publications

Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and Discovery

Witte O, Radu C, Czernin J. Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and[...]

Topological Data Analysis in the Assessment of Coronary Atherosclerosis: A Comprehensive Narrative Review

Singh Y, Hathaway QA, Farrelly C, Budoff MJ, Erickson B, Collins JD, Blaha MJ, Leiner T, Lopez-Jimenez F, Rozenblit J, Sarkar D, Carlsson G. Topological[...]

Coronary Artery Bypass Grafting Is Rarely Done in the Acute Care of ST-elevation Myocardial Infarction Patients Treated by Emergency Medical Services

Toy J, Lauer C, Kaji AH, Thomas JL, Megowan N, Bosson N, Gausche-Hill M, Dhawan P, Kloner RA, Rasnake S, French W, Schlesinger S. Coronary[...]